Maximize Value while Managing Risk

We continue to be on the forefront of science and have positioned our business development functions to attract additional intellectual property, know-how and commercialization opportunities—translating science into medicine while strengthening the offerings of our partners and portfolio companies.

Growth and Perpetuation for our Partners.

01

Earlier Stage

Identify intellectual property, know-how and potential R&D initiatives, portfolio companies and commercializations

Provide infrastructure, talent, and a pathway for successful commercialization through Origin

02

Transitional Stage

Groom operations and provide business, scientific and clinical guidance to achieve maximum value

Assist management in building business/clinical strategy, identifying partners and refining longer-term and commercialization plans

03

Later Stage

Assist management and scientific/medical team in full-scale build-out

Business development, corporate finance and advisory

Distribution Growth Drives Value

Through Origin’s unique combination of science, medicine, distribution, and first mover status, we are heavily focused on building market access and growing distribution opportunities for our portfolio companies.


Origin maintains one of the largest global distribution forces that benefits our portfolio companies with immediate, dedicated sales and marketing capabilities across all therapeutic areas.